TATA健康：截至二零二三年十二月三十一日止年度的全年业绩公告

TATA Health International Holdings Limited 1255 TATA —9(0.13)0.03 1. 2. 1717812 — 1212 — 572022(i)(ii) 1993(b)1993(b) 1993(b)1993(a)1994(a) 1028116215212772213974—114185 12345 3. 3.1 622 Shang Ying International Trade Holdings LimitedShang YingDevelopment LimitedShang Ying New Retail Group Holdings LtdShangYing Retail Plus Holdings Ltd Shang Ying New Retail Ltd Shang Ying BrandManagement Co., LtdSixth Avenue Plus Pty LtdSun Medical and Technology Investment Holdings Co., LimitedDermaco Pty LtdPharma Science Australia Pty. Ltd.Century Health Brands Pty Ltd 36,046,00045,931,00048,415,00016,172,000 (a) 50,000,000 (b) 12 4. 15 5. 8 1.2.3.4. (35,420) 10% 6. 7. 2,000,0008.25%2,000,00016.5%16.5%2,000,0008.25%2,000,00016.5% 16.5% 12%12%600,000600,000 30%30% 25%25% 8. 9. 32,294,0008,047,000242,845,000242,845,000 10. 306030901590 308,3985,54131601961,163619021053090—4788,8047,712 11. 303160619090 12. a. (2024)0339625(1)33—7 b. c.Shang Ying Capital Limited ShangYing CapitalLimited TATA GDP(3.2%)(–3.5%)7.8% 340055%16.2%4,06043.8%2.0398.0%34.7%Josef Seibel2 2.0%—12 TATA COVID-1998% COVID-19203,300,000141,400,00043.8%34.7%2.1% 0200,0002,400,0003,300,000 (i)(ii)(iii) DSG Securities (Hong Kong) Limited14,100,0002,500,000 100,000400,000 12 COVID-1916.2% 98%43.8%JosefSeibel2.5 207,500,000144,600,00043.5% 203,300,000141,400,00043.8% Clarks10.9%Josef Seibel189.3% 302721 4,100,0002,500,00064% 200,000100% 100,000400,000 56,800,00027.4%30,700,00021.2% 150,700,000113,900,00032.3%72.6%78.8% 6.8%8.3% 70,200,00033.8%70,400,00048.6% 1,700,0002,500,000 600,00033,100,00033,000,000 35,400,0002,500,000 40,000,00033,600,00018.9%5,000,00015,000,00015,000,00013,900,0008,600,000 –92.8%105.6% 3.7 123,993,617Great Wall International Investment X Limited51.06% 3.7 130150 C1 C3 3ShangYingInternational Trade Holdings LimitedShang YingNew Retail Group Holdings Limited 3.1 3.144,001,0001,052,00044,001,000 12 TATA